These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20651313)

  • 1. Use of granulocyte colony-stimulating factor in patients with severe sepsis or septic shock.
    Mohammad RA
    Am J Health Syst Pharm; 2010 Aug; 67(15):1238-45. PubMed ID: 20651313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
    Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
    Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of the use of granulocyte colony-stimulating factor in septic shock.
    Stephens DP; Fisher DA; Currie BJ
    Intern Med J; 2002 Apr; 32(4):143-8. PubMed ID: 11951925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filgrastim in patients with pneumonia and severe sepsis or septic shock.
    Wunderink R; Leeper K; Schein R; Nelson S; DeBoisblanc B; Fotheringham N; Logan E
    Chest; 2001 Feb; 119(2):523-9. PubMed ID: 11171733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand.
    Cheng AC; Limmathurotsakul D; Chierakul W; Getchalarat N; Wuthiekanun V; Stephens DP; Day NP; White NJ; Chaowagul W; Currie BJ; Peacock SJ
    Clin Infect Dis; 2007 Aug; 45(3):308-14. PubMed ID: 17599307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis.
    Cheng AC; Stephens DP; Anstey NM; Currie BJ
    Clin Infect Dis; 2004 Jan; 38(1):32-7. PubMed ID: 14679445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
    Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
    Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock.
    Schefold JC
    Crit Care; 2011; 15(2):136. PubMed ID: 21489333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure.
    Smith WS; Sumnicht GE; Sharpe RW; Samuelson D; Millard FE
    Blood; 1995 Aug; 86(4):1301-9. PubMed ID: 7543303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial.
    El-Ganzoury MM; El-Farrash RA; Saad AA; Mohamed AG; El-Sherbini IG
    Pediatr Hematol Oncol; 2012 Apr; 29(3):272-84. PubMed ID: 22475305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-lymphocyte Ratio After Granulocyte Colony Stimulating Factor Administration: an Early Prognostic Marker in Septic Shock Patients With Chemotherapy-Induced Febrile Neutropenia.
    Kim YJ; Kang J; Ryoo SM; Ahn S; Huh JW; Kim WY
    Shock; 2019 Aug; 52(2):160-165. PubMed ID: 30148761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
    JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient leukocytosis, granulocyte colony-stimulating factor plasma concentrations, and apoptosis determined by binding of annexin V by peripheral leukocytes in patients with severe sepsis.
    Weiss M; Elsharkawi M; Welt K; Schneider EM
    Ann N Y Acad Sci; 2003 Dec; 1010():742-7. PubMed ID: 15033821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin C for Sepsis and Septic Shock.
    Ammar MA; Ammar AA; Condeni MS; Bell CM
    Am J Ther; 2021 Jul; 28(6):e649-e679. PubMed ID: 34264892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847].
    Horisberger T; Harbarth S; Nadal D; Baenziger O; Fischer JE
    Crit Care; 2004 Dec; 8(6):R443-50. PubMed ID: 15566590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of glucocorticoids as adjunctive treatment for sepsis in the modern era.
    Marik PE
    Lancet Respir Med; 2018 Oct; 6(10):793-800. PubMed ID: 30006071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.